PPCB
PPCB
NASDAQ · Biotechnology

Propanc Biopharma Inc

$0.10
0.00 (-4.44%)
As of Mar 29, 11:05 PM ET ·
Financial Highlights (FY 2025)
Revenue
398.2K
Net Income
-29,112
Gross Margin
41.7%
Profit Margin
-7.3%
Rev Growth
+16.9%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 41.7% 41.7% 41.7%
Operating Margin -8.6% -7.9% -7.8%
Profit Margin -7.3% -8.8% -7.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 398.2K 400.3K 406.3K
Gross Profit 166.2K 167.1K 169.6K
Operating Income -34,045 -31,666 -31,873
Net Income -29,112 -35,289 -31,464
Gross Margin 41.7% 41.7% 41.7%
Operating Margin -8.6% -7.9% -7.8%
Profit Margin -7.3% -8.8% -7.7%
Rev Growth +16.9% +4.6% -8.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 261.2K 296.5K 237.0K
Total Equity 1.97M 1.98M 1.80M
D/E Ratio 0.13 0.15 0.13
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -48,158 -49,842 -45,919
Free Cash Flow -34,661 -49,903 -42,011